Summit Therapeutics Inc. (SMMT) — Stock Score Summary

Summit Therapeutics Inc. (SMMT) has a MoatMap StockRank of 20/100 based on Quality (39/100), Value (30/100), and Momentum (36/100) factor scores. The current signal is STRONG SELL. Summit Therapeutics has seen a massive run-up on positive clinical data for its oncology asset, ivonescimab. However, it is pre-revenue, highly volatile, and lacks the predictable free cash flows and structural moats of a Terry Smith compounder.

Summit Therapeutics Inc. is a biopharmaceutical company dedicated to developing and commercializing novel medicines for serious infectious diseases and oncology. The company's pipeline includes late-stage clinical candidates, particularly in treating multi-drug resistant infections and cancer. It leverages strategic partnerships and R&D efforts to address significant unmet medical needs in challenging therapeutic areas.

Key Financial Metrics

Price$15.07
Market Cap$13.5B
P/E (Forward)-12.54
Price/Book17.46
Return on Equity-271.0%
Return on Invested Capital-159.2%
Debt/Equity3.67
Gross Margin0.0%
Operating Margin0.0%
Free Cash Flow$70M

Summit Therapeutics Inc. operates in the Biotechnology industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Summit Therapeutics Inc.’s (SMMT) StockRank?
MoatMap’s StockRank for Summit Therapeutics Inc. (SMMT) is 20/100, with a Strong Sell signal. It is a composite of Quality (39), Value (30), and Momentum (36) factor ranks across MoatMap’s 19,000+ stock universe.
Does Summit Therapeutics Inc. have an economic moat?
Summit Therapeutics Inc. (SMMT) has a Quality factor score of 39/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Summit Therapeutics Inc. a buy, hold, or sell?
MoatMap’s current signal for Summit Therapeutics Inc. (SMMT) is Strong Sell, based on a StockRank of 20/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Summit Therapeutics Inc. in?
Summit Therapeutics Inc. (SMMT) operates in the Healthcare sector, specifically the Biotechnology industry (United States).
Browse all ranked stocksSMMT deep dive reportAI ChampionsHow we score stocksSense-check another stock